We first determined the mRNA expression status of FBXW7 and p73 in PCa tumors to understand their clinical significance as tumor suppressors using TCGA PRAD dataset (n = 623) analysis, which confirmed their loss of expression in PCa tumors compared to normal prostate tissues. This evidence concerns the gene FBXW7 and posterior cortical atrophy.